Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression � In Vivo Validation
75F40126Q00382 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) solicitation, with responses due 2026-09-10. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
Title: Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression In Vivo Validation Agency: U.S. Food and Drug Administration (FDA) Notice Type: Presolicitation: Firm-Fixed Price DEA surveillance data show that street fentanyl is frequently adulterated w
Comparable recent awards in RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
| Winner | Award value | Offers | Date |
|---|---|---|---|
| AMERICAN TYPE CULTURE COLLECTION | $4.3M | n/a | 2026-07-01 |
| REGENTS OF THE UNIVERSITY OF MICHIGAN | $17.5M | n/a | 2026-06-30 |
| CERAMEDIX HOLDING, LLC | $4.5M | 18 | 2026-06-24 |
| TWIST BIOSCIENCE CORPORATION | $47K | 1 | 2026-06-24 |
| CHROMOLOGIC LLC | $4.5M | 18 | 2026-06-24 |
Questions
What is solicitation 75F40126Q00382?
Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression � In Vivo Validation, issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 541714 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)). Responses are due 2026-09-10.
What do similar contracts close for?
Comparable closed awards in this category ran from $47K to $17.5M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is 75F40126Q00382 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.